Gocke J, Karlen V, Beckmann M, Pöschke P, Emons J (2026)
Publication Type: Journal article
Publication year: 2026
DOI: 10.1007/s00761-026-01987-2
Follow-up care for endometrial carcinoma should be guideline-based and carried out in close interdisciplinary collaboration among the involved specialties. Its aims are the early detection of recurrence, the management of treatment- and surgery-related sequelae, and the provision of psychosocial support for patients. Risk stratification is playing an increasingly important role in structuring follow-up care. In stages I–II, the focus is on a structured medical history and gynecologic examination. These assessments are performed every 6 months for up to 5 years after completion of treatment. In patients with high-risk or advanced tumors, follow-up is conducted more frequently—usually every 3 months during the first 3 years—and may be supplemented by extended imaging. With the introduction of increasingly complex treatment concepts, particularly immune checkpoint inhibitors, the management of treatment-related adverse effects is becoming increasingly important.
APA:
Gocke, J., Karlen, V., Beckmann, M., Pöschke, P., & Emons, J. (2026). Guideline-based follow-up care for endometrial cancer—modified through risk stratification, supportive therapy, and survivorship programs Leitlinienkonforme Nachsorge beim Endometriumkarzinom – modifiziert durch Risikoadaptation, Supportivtherapie und Survivorship-Programme. Die Onkologie. https://doi.org/10.1007/s00761-026-01987-2
MLA:
Gocke, Julia, et al. "Guideline-based follow-up care for endometrial cancer—modified through risk stratification, supportive therapy, and survivorship programs Leitlinienkonforme Nachsorge beim Endometriumkarzinom – modifiziert durch Risikoadaptation, Supportivtherapie und Survivorship-Programme." Die Onkologie (2026).
BibTeX: Download